GMP IPO Watch logo GMP IPO Watch
Equity Scheme - Sectoral/ Thematic

HDFC Pharma and Healthcare Fund

Direct Plan · IDCW Option · HDFC Mutual Fund

Risk: Very High Risk
52W Low ₹16.83 2 Feb 2026 52W High ₹23.56 12 Nov 2026
₹23.4930 NAV as of 13 Nov 2026 -0.28% day change
ISININF179KC1HP8
Scheme Code152081
StructureOpen Ended Schemes
Fund HouseHDFC Asset Management Company Limited
AUM (avg. July - September 2026)₹14.59 Cr
Expense Ratio (as of 12 Nov 2026)1.01%
Min. Investment₹100
Inception Date14 Sept 2023
BenchmarkBSE Healthcare Index (TRI)
Portfolio Turnover38.18%
NFO PeriodSeptember 14, 2023 – September 28, 2023

Returns

1Y +31.62%
3Y +31.27%
Since Inception +31.75%

Annualised (CAGR) returns for periods over a year.

Want to invest in this fund?

Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.

Open Free Account

Rank in Category

PeriodThis FundCategory Avg.Rank
1W +2.97% +1.80% 40 of 255
1M +9.28% +5.00% 7 of 255
3M +5.99% -0.55% 5 of 253
6M +20.02% +7.92% 13 of 251
YTD +33.08% +4.96% 3 of 255
1Y +31.62% +4.71% 3 of 232
2Y +21.08% +5.71% 4 of 188
3Y +31.27% +12.89% 3 of 142
INCEPTION +31.75% — —

Ranked among: Equity Scheme - Sectoral/ Thematic.

Rolling Returns

PeriodAverageBestWorstPositive PeriodsConsistency
3M +7.24% +29.66% -12.76% 80% 33%
6M +13.91% +38.32% -8.15% 87% 38%
1Y +24.64% +67.32% +1.71% 100% 47%
2Y +22.89% +34.63% +12.64% 100% 48%
3Y +29.75% +31.42% +27.78% 100% 52%

Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.

NAV History

AUM Trend (₹ Cr, quarterly average)

Expense Ratio Trend

Portfolio · Oct 2026

Asset Allocation

  • Equity98.79%
  • Debt0.00%
  • Cash1.21%
  • Other0.00%

Market Cap Split

  • Large Cap29.78%
  • Mid Cap31.57%
  • Small Cap37.44%
  • Others1.21%

Fundamentals

FundCategory
P/E45.0742.16
P/B6.075.82
Price / Sales5.945.71
Price / Cash Flow31.8330.59
Dividend Yield (%)0.480.60
Holdings38
Top 5 Stocks33.78%
Top 10 Stocks51.70%
Top 3 Sectors97.90%

Holdings · Oct 2026

HoldingSectorWeightChange (1M)
Divis Laboratories Pharmaceuticals & Biotechnology 9.44% +0.05%
Sun Pharmaceutical Pharmaceuticals & Biotechnology 7.74% -0.54%
Dr Reddys Laboratories Pharmaceuticals & Biotechnology 6.66% +3.47%
Apollo Hospitals Equity 5.19% +1.50%
Alkem Laboratories Pharmaceuticals & Biotechnology 4.75% +0.11%
Cipla Pharmaceuticals & Biotechnology 4.06% -0.09%
Acutaas Chemicals Pharmaceuticals & Biotechnology 3.70% +0.52%
Max Healthcare Institute Equity 3.44% -0.17%
Aster DM Quality Care Equity 3.37% -0.19%
Lupin Pharmaceuticals & Biotechnology 3.35% -0.20%
Torrent Pharmaceuticals Pharmaceuticals & Biotechnology 3.35% -0.30%
Neuland Laboratories Pharmaceuticals & Biotechnology 2.96% -0.28%
Anthem Biosciences Pharmaceuticals & Biotechnology 2.92% -0.25%
Shilpa Medicare Pharmaceuticals & Biotechnology 2.92% -0.31%
Rubicon Research Pharmaceuticals & Biotechnology 2.69% +0.17%
View all 40 holdings
Global Health Equity 2.52% -0.20%
Paras Healthcare Equity 2.34% —
Glenmark Pharmaceuticals Pharmaceuticals & Biotechnology 1.96% -0.13%
IPCA Laboratories Pharmaceuticals & Biotechnology 1.93% -1.05%
Vijaya Diagnostic Centre Equity 1.92% -0.08%
Krishna Institute of Medical Sciences Equity 1.89% -0.21%
Molbio Diagnostics Equity 1.87% -0.14%
Zydus Life Science Pharmaceuticals & Biotechnology 1.86% +0.04%
TREPS - Tri-party Repo Reverse Repo / TREPS 1.77% —
Sai Life Sciences Pharmaceuticals & Biotechnology 1.74% +0.16%
Jupiter Life Line Hospital Equity 1.66% -0.02%
Metropolis Healthcare Equity 1.61% -0.06%
Wockhardt Pharmaceuticals & Biotechnology 1.47% -0.24%
Symbiotec Pharmalab Pharmaceuticals & Biotechnology 1.38% +0.02%
Biocon Pharmaceuticals & Biotechnology 1.33% -0.14%
Gland Pharma Pharmaceuticals & Biotechnology 1.05% -0.73%
Corona Remedies Pharmaceuticals & Biotechnology 1.02% -0.02%
Thyrocare Technologies Equity 0.90% -0.20%
Entero Healthcare Solutions Retailing 0.89% -0.12%
Eris Lifesciences Pharmaceuticals & Biotechnology 0.86% -0.06%
Jubilant Pharmova Pharmaceuticals & Biotechnology 0.80% -0.13%
Bajaj HealthCare Pharmaceuticals & Biotechnology 0.48% -0.05%
Evonile Pharma Pharmaceuticals & Biotechnology 0.46% -0.09%
Laxmi Dental Equity 0.31% -0.04%
Net Current Assets Net Current Assets -0.56% —

Sector Allocation · Oct 2026

Risk Metrics

Standard Deviation

PeriodFundCategory
1Y 13.95 16.50 Low Volatility
3Y 14.31 16.17 Low Volatility
What is this?

Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.

Sharpe Ratio

PeriodFundCategory
1Y 1.15 -0.32 Above Average
3Y 1.43 -0.45 Above Average
What is this?

Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.64% (published 2026-11-06).

Sortino Ratio

PeriodFundCategory
1Y 3.19 0.50 Above Average
3Y 2.96 1.19 Above Average
What is this?

Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.

Beta

PeriodFundCategory
1Y 1.03 0.96 Poor Risk Adjusted Returns
3Y 0.98 0.96 Poor Risk Adjusted Returns
What is this?

This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.

Compare With Peers

Scheme 1Y3Y5YSince Inception
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
+58.57% +44.52% — +22.82%
Kotak Healthcare Fund
Regular Plan · IDCW Option
+32.17% — — +22.23%
Mirae Asset Healthcare Fund
Direct Plan · Growth
+27.91% +24.41% +17.87% +22.59%
SBI Automotive Opportunities Fund
Direct Plan · IDCW
+26.48% — — +13.22%
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
+26.27% — — +14.24%
Edelweiss Recently Listed IPO Fund
Regular Plan · Growth
+25.91% +17.02% +9.91% +15.09%
SBI HEALTHCARE OPPORTUNITIES FUND
Regular Plan · IDCW
+24.84% +24.13% +19.38% +12.43%
WhiteOak Capital Pharma and Healthcare Fund
Regular Plan · Growth Option
+24.21% — — +22.33%
Bajaj Finserv Healthcare Fund
Regular Plan · Growth
+22.05% — — +10.27%
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
+21.93% +19.54% +12.36% +15.87%

More From HDFC Asset Management Company Limited

Scheme 1Y3Y5YSince Inception
HDFC Defence Fund
Direct Plan · Growth Option
+20.36% +33.63% — +38.01%
HDFC INNOVATION FUND
Direct Plan · IDCW Option
+18.61% — — +17.21%
HDFC Developed World Overseas Equity Passive FOF
Direct plan · Growth
+17.46% +25.27% +15.05% +16.02%
HDFC NIFTY PSU BANK ETF
Growth Option
+11.94% — — +15.46%
HDFC Transportation and Logistics Fund
Direct Plan · Growth Option
+10.10% +24.77% — +24.95%
HDFC Manufacturing Fund
Direct Plan · IDCW
+7.65% — — +8.26%
HDFC Silver ETF
Growth Option
+7.52% +35.05% — +32.47%
HDFC CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Direct Plan · Growth Option
+7.04% — — +7.02%
HDFC NIFTY Private Bank ETF
Growth Option
+6.96% +9.96% — +9.04%
HDFC Credit Risk Fund
Direct Plan · Growth Option
+6.65% +8.13% +7.13% +8.65%

About This Scheme

Investment Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

Stated Asset Allocation

Equity and Equity related instruments of Pharma and healthcare companies/entities# : 80%- 100%; Equity and equity related instruments of companies/entities other than above: 0% - 20%; Units of InvITs: 0% - 10%; Money market instruments, Other liquid instruments and Units of Mutual Fund^^: 0% - 20%; Gold and Silver instruments: 0% - 20% #Indicative list of businesses forming part of the Pharma and healthcare companies/entities are as follows: • Pharmaceutical • Healthcare • Hospitals & Diagnostics • Health IT services • Research and/or Manufacturing Services related to healthcare • Distribution related to healthcare • Medical Equipment • Hygiene • And any other business or service directly or indirectly forming part of the pharma, healthcare and allied sectors forming part of the Benchmark Index. ^^Units of Domestic Mutual Funds shall only include Overnight Funds, Liquid Funds and Money Market Mutual Funds. Further other liquid instruments shall include cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by SEBI from time to time. For detailed asset allocation, refer Scheme Information Document (SID) available on the website.

Exit Load

In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment.

Fund Managers

FM 1 - Mr. Nikhil Mathur, FM 2 - Mr. Gopal Agrawal, FM 3 - Mr. Bhagyesh Kagalkar

FM 1 - Fund Manager of the scheme, FM 2 - Fund Manager for Overseas Investments, FM 3 - Fund Manager for investments in Gold/Silver instruments

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.

Market Open · Closes 3:30 PM
NSE BSE NFO BFO CDS BCD MCX NSCOM